| Catalog Number |
TMTB10 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Unspecified Infection (1930)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Zimvie complaint (b)(4).A4: patient weight is not provided / unknown.B3: date of event is not provided / unknown.E1: initial reporter¿s title and last name are not provided / unknown.A summary investigation has been completed for infection events identifying that a definitive root cause cannot be identified due to the wide range of external (non-design/ non-manufacturing related) factors potentially impacting the sterility of the implant and its environment.Should additional information be received which indicates that the device may have caused or contributed to the infection event, an additional report will be submitted.H3 other text : summary investigation.
|
| |
|
Event or Problem Description
|
|
Infection was reported and patient was placed on clindamycin again.Symptoms as a result of the event: abscess, pain, inflammation.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being submitted to report additional information.Dhr review was completed for the subject lot number.No deviations or non-conformances, which could have caused or contributed to the reported event, were noted as part of the dhr.Sterilization record was reviewed and verified to have passed all sterilization activities with no issues or nonconformities identified.Complaint history review was performed for the reported lot number for similar events and four other complaints were identified.As documented in the summary investigation, contributing factors for the reported event likely exist outside of zimvie control, including those related to patient biological factors/condition and surgical technique.Based on the summary investigation, no malfunction occurred upon investigation.The reported event remains non-verifiable as it is a medical condition.Monthly trending to date has not identified any statistical triggers suggesting potential design or manufacturing related issues.Previously completed investigations for the infection of an implant have not identified any signals indicating potential non-conformances impacting the manufacturing and sterilization processes.Therefore, escalation to capa is not required.
|
| |
|
Event or Problem Description
|
|
No additional or corrected information to report.
|
| |
|
Search Alerts/Recalls
|